Mangoceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	1.49	0.06	0.74	0.68	0.02
Cash & Short-Term Investments	1.49	0.06	0.74	0.68	0.02
Cash Growth	2434.12%	-92.06%	8.22%	2928.20%	-
Inventory	-	-	0.02	-	-
Prepaid Expenses	0.01	-	-	0.01	-
Other Current Assets	0.05	0.02	0.08	-	-
Total Current Assets	1.55	0.08	0.84	0.69	0.02
Property, Plant & Equipment	0.31	0.18	0.22	0.29	-
Other Intangible Assets	14.23	15.23	-	-	-
Other Long-Term Assets	-	-0.12	-	0.02	-
Total Assets	16.09	15.37	1.05	1	0.02
Accounts Payable	0.42	0.84	0.14	0.03	-
Accrued Expenses	0.01	-	0.01	0	-
Short-Term Debt	-	0.15	-	0.17	0.04
Current Portion of Leases	0.31	0.06	0.06	0.06	-
Other Current Liabilities	0.16	0.37	-	-	-
Total Current Liabilities	0.89	1.43	0.21	0.26	0.04
Long-Term Leases	-	-	0.06	0.13	-
Total Liabilities	0.89	1.43	0.28	0.39	0.04
Common Stock	0	0	0	0	0
Additional Paid-In Capital	55.52	34.79	12	2.63	0
Retained Earnings	-40.65	-20	-11.23	-2.02	-0.02
Comprehensive Income & Other	0.32	-0.84	-	-	-
Total Common Equity	15.2	13.95	0.77	0.61	-0.02
Minority Interest	-0	-0	-	-	-
Shareholders' Equity	15.2	13.95	0.77	0.61	-0.02
Total Liabilities & Equity	16.09	15.37	1.05	1	0.02
Total Debt	0.31	0.21	0.13	0.35	0.04
Net Cash (Debt)	1.18	-0.16	0.61	0.33	-0.02
Net Cash Growth	-	-	84.95%	-	-
Net Cash Per Share	0.12	-0.08	0.57	0.46	-0.03
Filing Date Shares Outstanding	16.97	5.17	1.53	0.89	0.53
Total Common Shares Outstanding	15.89	3.25	1.43	0.89	0.53
Working Capital	0.66	-1.35	0.62	0.43	-0.02
Book Value Per Share	0.96	4.30	0.54	0.69	-0.03
Tangible Book Value	0.97	-1.29	0.77	0.61	-0.02
Tangible Book Value Per Share	0.06	-0.40	0.54	0.69	-0.03
Machinery	0.01	0.12	0.12	0.12	-

Source: S&P Capital IQ. Standard template. Financial Sources.